AltamarCAM Partners, an independent private asset manager with over €22 billion in committed investment, has reached an agreement with Cleon Capital to lead the replacement of several family offices, that have held minority stakes alongside Cleon Capital in the Italian nutraceutical company Labomar since 2020.

 

AltamarCAM Partners will also contribute new funds to the project. With this transaction, AltamarCAM Partners joins the group of international institutional investors and high-net-worth individuals investing in projects led by Cleon Capital in Spain and Italy.

Read the complete article downloading this pdf.